ES281704A1 - Un procedimiento para la fabricacion de formulaciones medicamentosas de descarga sotenida - Google Patents
Un procedimiento para la fabricacion de formulaciones medicamentosas de descarga sotenidaInfo
- Publication number
- ES281704A1 ES281704A1 ES0281704A ES281704A ES281704A1 ES 281704 A1 ES281704 A1 ES 281704A1 ES 0281704 A ES0281704 A ES 0281704A ES 281704 A ES281704 A ES 281704A ES 281704 A1 ES281704 A1 ES 281704A1
- Authority
- ES
- Spain
- Prior art keywords
- polyoxyethylene glycol
- medicament
- tablets
- esters
- acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14642261A | 1961-10-20 | 1961-10-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
ES281704A1 true ES281704A1 (es) | 1963-04-16 |
Family
ID=22517286
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES0281704A Expired ES281704A1 (es) | 1961-10-20 | 1962-10-19 | Un procedimiento para la fabricacion de formulaciones medicamentosas de descarga sotenida |
Country Status (6)
Country | Link |
---|---|
BE (1) | BE623704A (es) |
DE (1) | DE1219176B (es) |
ES (1) | ES281704A1 (es) |
FR (1) | FR2172M (es) |
GB (1) | GB967610A (es) |
MY (1) | MY6600083A (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK132572C (da) * | 1971-11-17 | 1976-05-31 | Colgate Palmolive Co | Tandpasta |
SE418247B (sv) * | 1975-11-17 | 1981-05-18 | Haessle Ab | Sett att framstella kroppar med reglerad frigoring av en aktiv komponent |
DE3217071A1 (de) * | 1982-05-06 | 1983-11-10 | Rüdiger Dr. 6365 Rosbach Gröning | Arzneimittel fuer die perorale applikation mit verbesserter biologischer verfuegbarkeit der wirkstoffe |
US5082655A (en) * | 1984-07-23 | 1992-01-21 | Zetachron, Inc. | Pharmaceutical composition for drugs subject to supercooling |
US4629621A (en) * | 1984-07-23 | 1986-12-16 | Zetachron, Inc. | Erodible matrix for sustained release bioactive composition |
US4797288A (en) * | 1984-10-05 | 1989-01-10 | Warner-Lambert Company | Novel drug delivery system |
US4828857A (en) * | 1984-10-05 | 1989-05-09 | Warner-Lambert Company | Novel sweetener delivery systems |
US4804548A (en) * | 1984-10-05 | 1989-02-14 | Warner-Lambert Company | Novel sweetener delivery systems |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2918411A (en) * | 1957-11-01 | 1959-12-22 | Olin Mathieson | Pharmaceutical preparations |
-
0
- BE BE623704D patent/BE623704A/xx unknown
-
1962
- 1962-09-28 DE DEH47032A patent/DE1219176B/de active Pending
- 1962-10-10 GB GB38360/62A patent/GB967610A/en not_active Expired
- 1962-10-18 FR FR912603A patent/FR2172M/fr active Active
- 1962-10-19 ES ES0281704A patent/ES281704A1/es not_active Expired
-
1966
- 1966-12-31 MY MY6600083A patent/MY6600083A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
GB967610A (en) | 1964-08-26 |
DE1219176B (de) | 1966-06-16 |
MY6600083A (en) | 1966-12-31 |
FR2172M (fr) | 1963-11-25 |
BE623704A (es) |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1030127A (en) | Improvements in or relating to method of preparing sustained release pharmaceutical pellets and product thereof | |
US6491950B1 (en) | Controlled release pharmaceutical composition | |
US6524615B2 (en) | Controlled release pharmaceutical composition | |
ES2251991T3 (es) | Composiciones farmaceuticas orales que contienen trigliceridos de cadena larga y tensioactivos lipofilicos. | |
US4983399A (en) | Direct compression carrier composition | |
AU594264B2 (en) | Therapeutic agents | |
US3082154A (en) | Improved free-flowing coated antimalarial salts in particulate form | |
PT98879A (pt) | Processo para a preparacao de microcapsulas mascaveis esferoidais revestidas | |
JP2005508301A5 (es) | ||
ES281704A1 (es) | Un procedimiento para la fabricacion de formulaciones medicamentosas de descarga sotenida | |
US3061510A (en) | Radioactive iodinated (i131) fatty material admixed with wax-like material in capsule | |
US5736542A (en) | Pharmaceutical compositions containing a staurosporine | |
US3136695A (en) | Anhydrous thixotropic gel sustained release therapeutic compositions and method of preparation | |
EP0574221B1 (en) | Pharmaceutical stable formulations of nicorandil | |
CA2535340A1 (en) | Fast dissolving tablet | |
SK283442B6 (sk) | Farmaceutický prípravok na orálne podanie | |
EP0230332A1 (en) | A pharmaceutical composition with sustained release of the active component and a process for the preparation thereof | |
US3450821A (en) | Stable compositions containing eicosatetrayn - (5,8,11,14) - oic-(1) acid and derivatives thereof | |
GB1443923A (en) | Sustained release compositions | |
US2895881A (en) | Quinidine gluconate sustained medication tablet | |
JPH07506845A (ja) | セレジリンを含有する新規組成物 | |
JPH1045629A (ja) | 活性成分の調節放出のための安定化親油性マトリックスを基本とする医薬組成物 | |
US11690835B2 (en) | Formulation | |
CN102406619A (zh) | 一种缓释微丸及其制备方法 | |
AT232648B (de) | Verfahren zur Herstellung einer Arzneimittelzubereitung mit verzögerter Wirkstoff-Freisetzung |